Stock ScreenerStock IdeasHigh Risk, High Reward
High Risk, High Reward Stocks
Speculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!

Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
Ticker
Company
Zen Rating
Growth
Market Cap
Revenue
EBITDA
Earnings
EPS
Rev. Y/Y
Rev. 5Y
Earn. Y/Y
Earn. 5Y
Earnings Date
KALA
KALA BIO INC
$3.12M$0.00-$30.62M-$35.84M-$5.66N/A-100.00%N/AN/A
FBLG
FIBROBIOLOGICS INC
$12.97M$0.00-$17.74M-$18.50M-$0.48N/AN/AN/AN/A
PSTV
PLUS THERAPEUTICS INC
$38.89M$5.26M-$16.33M-$20.58M-$1.70-8.16%28.67%N/AN/A
RCKT
ROCKET PHARMACEUTICALS INC
$373.37M$0.00-$227.85M-$240.91M-$2.25N/AN/AN/AN/A2026-03-02
NRXP
NRX PHARMACEUTICALS INC
$49.87M$242.00k-$38.02M-$38.06M-$2.36N/AN/AN/AN/A
CLGN
COLLPLANT BIOTECHNOLOGIES LTD
$7.10M$2.48M-$11.54M-$12.16M-$1.02280.77%-16.28%N/AN/A2026-04-02
NAKA
NAKAMOTO INC
$111.28M$1.98M-$89.61M-$90.49M-$1.11-31.13%N/AN/AN/A2026-02-20
OSTX
OS THERAPIES INC
$41.20M$0.00-$18.04M-$20.26M-$0.82N/AN/AN/AN/A2026-04-06
SGMO
SANGAMO THERAPEUTICS INC
$122.15M$32.88M-$101.50M-$108.91M-$0.45-37.13%-25.91%N/AN/A2026-02-25
SLE
SUPER LEAGUE ENTERPRISE INC
$3.37M$11.57M-$10.72M-$15.86M-$303.00-48.05%49.54%N/AN/A2026-03-26
TLRY
TILRAY BRANDS INC
$883.12M$837.32M-$2.11B-$2.11B-$23.110.98%N/AN/AN/A
PDSB
PDS BIOTECHNOLOGY CORP
$32.87M$0.00-$32.21M-$34.88M-$0.82N/AN/AN/AN/A2026-03-26
RVPH
REVIVA PHARMACEUTICALS HOLDINGS INC
$29.34M$0.00-$22.71M-$22.76M-$0.46N/AN/AN/AN/A2026-03-23
GUTS
FRACTYL HEALTH INC
$57.70M$3.00k-$119.58M-$122.20M-$2.30-96.91%N/AN/AN/A2026-04-06
ACET
ADICET BIO INC
$67.62M$0.00-$105.29M-$115.01M-$20.00N/A-100.00%N/AN/A2026-03-05
ENLV
ENLIVEX THERAPEUTICS LTD
$27.21M$0.00-$14.51M-$12.70M-$0.55N/AN/AN/AN/A2026-02-25
IFRX
INFLARX NV
$59.55M$73.07k-$46.08M-$46.63M-$0.70-60.51%N/AN/AN/A2026-03-19
SNTI
SENTI BIOSCIENCES INC
$24.19M$0.00-$43.38M-$47.58M-$3.28N/AN/AN/AN/A
TVRD
TVARDI THERAPEUTICS INC
$33.77M$4.02M-$8.73M-$13.95M-$8.50-21.70%-31.91%N/AN/A2026-03-11
VNRX
VOLITIONRX LTD
$26.40M$1.47M-$21.14M-$22.88M-$0.2314.48%197.53%N/AN/A2026-03-31
HUMA
HUMACYTE INC
$202.25M$1.57M-$18.88M-$36.97M-$0.23N/AN/AN/AN/A2026-03-26
PALI
PALISADE BIO INC
$251.82M$0.00-$11.10M-$11.23M-$2.12N/A-100.00%N/AN/A
ACRV
ACRIVON THERAPEUTICS INC
$50.17M$0.00-$79.45M-$81.75M-$2.12N/AN/AN/AN/A
TNYA
TENAYA THERAPEUTICS INC
$105.07M$0.00-$82.99M-$94.26M-$0.77N/AN/AN/AN/A2026-03-24
CTSO
CYTOSORBENTS CORP
$40.70M$34.35M-$8.52M-$10.59M-$0.1815.09%-1.19%N/AN/A2026-03-11
INTZ
INTRUSION INC
$17.93M$7.29M-$6.25M-$8.19M-$0.4533.49%-0.86%N/AN/A
RANI
RANI THERAPEUTICS HOLDINGS INC
$157.97M$1.20M-$21.76M-$28.32M-$0.79N/AN/AN/AN/A
CAN
CANAAN INC
$300.33M$529.74MN/A-$210.27M-$0.4896.69%52.18%N/AN/A2026-04-15
APRE
APREA THERAPEUTICS INC
$4.59M$488.24k-$13.83M-$13.04M-$2.13-62.75%N/AN/AN/A
MREO
MEREO BIOPHARMA GROUP PLC
$66.99M$500.00k-$42.09M-$41.57M-$0.30-50.00%N/AN/AN/A2026-04-01
CABA
CABALETTA BIO INC
$301.31M$0.00-$145.48M-$158.52M-$2.53N/AN/AN/AN/A2026-03-12
HOWL
WEREWOLF THERAPEUTICS INC
$31.99M$0.00-$65.24M-$72.84M-$1.62-100.00%N/AN/AN/A2026-03-19
HELP
CYBIN INC
$354.25M$0.00-$96.64M-$96.75M-$3.64N/AN/AN/AN/A
TCRX
TSCAN THERAPEUTICS INC
$57.88M$8.42M-$136.89M-$142.60M-$1.12-10.03%N/AN/AN/A2026-03-11
LUNG
PULMONX CORP
$58.57M$91.66M-$50.52M-$56.75M-$1.4115.59%22.48%N/AN/A2026-02-25
CRBU
CARIBOU BIOSCIENCES INC
$151.42M$9.30M-$151.08M-$157.13M-$1.70-19.00%N/AN/AN/A2026-03-16
AUTL
AUTOLUS THERAPEUTICS PLC
$415.18M$51.13M-$223.92M-$224.80M-$0.83406.67%99.45%N/AN/A2026-03-10
DARE
DARE BIOSCIENCE INC
$23.58M-$57.13k-$16.36M-$17.46M-$1.88N/AN/AN/AN/A
DEFT
DEFI TECHNOLOGIES INC
$271.75MN/AN/AN/AN/AN/AN/AN/AN/A
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.